These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32522054)

  • 21. Stability of 4-DMAP in solution.
    Wang DP; Chang LC; Wang MT
    Drug Dev Ind Pharm; 2001 Oct; 27(9):997-1001. PubMed ID: 11763479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LABEL-FREE BIO-AFFINITY MASS SPECTROMETRY FOR SCREENING AND LOCATING BIOACTIVE MOLECULES.
    Tao Y; Yan J; Cai B
    Mass Spectrom Rev; 2021 Jan; 40(1):53-71. PubMed ID: 31755145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of fluorescence imaging-based assay for screening cardioprotective compounds from medicinal plants.
    Wang Y; Zhao X; Gao X; Nie X; Yang Y; Fan X
    Anal Chim Acta; 2011 Sep; 702(1):87-94. PubMed ID: 21819864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a Dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates.
    Alelyunas YW; Liu R; Pelosi-Kilby L; Shen C
    Eur J Pharm Sci; 2009 May; 37(2):172-82. PubMed ID: 19429424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
    Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN
    Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical screening in zebrafish for novel biological and therapeutic discovery.
    Wiley DS; Redfield SE; Zon LI
    Methods Cell Biol; 2017; 138():651-679. PubMed ID: 28129862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLP: A requirement in cell therapies - perspectives for the cardiovascular field.
    Müller-Ruch U; Skorska A; Lemcke H; Steinhoff G; David R
    Adv Drug Deliv Rev; 2020; 165-166():96-104. PubMed ID: 32305352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matching pH values for antibody stabilization and crystallization suggest rationale for accelerated development of biotherapeutic drugs.
    Sjuts H; Schreuder H; Engel CK; Bussemer T; Gokarn Y
    Drug Dev Res; 2020 May; 81(3):329-337. PubMed ID: 31758731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Operationalizing the Use of Biofabricated Tissue Models as Preclinical Screening Platforms for Drug Discovery and Development.
    Jung O; Song MJ; Ferrer M
    SLAS Discov; 2021 Oct; 26(9):1164-1176. PubMed ID: 34269079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of Optimized Bovine Serum Albumin Level in a High-Throughput Caco-2 Assay Enabled Accurate Permeability Assessment for Lipophilic Compounds.
    Cai X; Madari S; Walker A; Paiva A; Li Y; Herbst J; Shou W; Weller H
    SLAS Discov; 2019 Aug; 24(7):738-744. PubMed ID: 31076010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solubility and permeability measurement and applications in drug discovery.
    Burton PS; Goodwin JT
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):101-11. PubMed ID: 20053165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
    Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
    J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screening normalized to biological response: application to antiviral drug discovery.
    Patel DA; Patel AC; Nolan WC; Huang G; Romero AG; Charlton N; Agapov E; Zhang Y; Holtzman MJ
    J Biomol Screen; 2014 Jan; 19(1):119-30. PubMed ID: 23860224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis.
    Booij TH; Price LS; Danen EHJ
    SLAS Discov; 2019 Jul; 24(6):615-627. PubMed ID: 30817892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrafast mass spectrometry based bioanalytical method for digoxin supporting an in vitro P-glycoprotein (P-gp) inhibition screen.
    Wagner AD; Kolb JM; Ozbal CC; Herbst JJ; Olah TV; Weller HN; Zvyaga TA; Shou WZ
    Rapid Commun Mass Spectrom; 2011 May; 25(9):1231-40. PubMed ID: 21488121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Developability assessment with case studies highlighting the decision taking].
    Dumas J; Sévérac A; Lemoine C; Huille S; Rak A; Prades C
    Med Sci (Paris); 2019 Dec; 35(12):1171-1174. PubMed ID: 31903933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput fractionation of natural products for drug discovery.
    Tu Y; Yan B
    Methods Mol Biol; 2012; 918():117-26. PubMed ID: 22893289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of hydrolytic stability screening methods for early drug discovery with high differentiation and predictive power.
    Wang J; Ottosson J; Tentarelli S
    J Pharm Biomed Anal; 2023 Sep; 233():115478. PubMed ID: 37245329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated MALDI Target Preparation Concept: Providing Ultra-High-Throughput Mass Spectrometry-Based Screening for Drug Discovery.
    Winter M; Ries R; Kleiner C; Bischoff D; Luippold AH; Bretschneider T; Büttner FH
    SLAS Technol; 2019 Apr; 24(2):209-221. PubMed ID: 30074850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.